Shanghai Pharmaceuticals Holding Co (SHSE:601607) ROCE % : 4.25% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Pharmaceuticals Holding Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 4.25%.

Shanghai Pharmaceuticals Holding Co ROCE % Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co ROCE % Chart

Shanghai Pharmaceuticals Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

12.72

13.91

14.57

13.20

10.10

Shanghai Pharmaceuticals Holding Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															7.79	13.32	11.12	11.06	4.25

Shanghai Pharmaceuticals Holding Co ROCE % Calculation

Shanghai Pharmaceuticals Holding Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	8939.281	/	( ( (198134.901 - 110691.046)	+	(211972.534 - 122371.879) )	/ 2 )
	=	8939.281	/	( (87443.855	+	89600.655)	/ 2 )
	=	8939.281	/	88522.255
	=	10.10 %

Shanghai Pharmaceuticals Holding Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	3835.988	/	( ( (213146.38 - 122429.675)	+	(211972.534 - 122371.879) )	/ 2 )
	=	3835.988	/	( ( 90716.705	+	89600.655 )	/ 2 )
	=	3835.988	/	90158.68
	=	4.25 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Pharmaceuticals Holding Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SHPMY:USA SHPMF:USA 02607:Hong Kong S1R:Germany

Address

No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020

Website

https://www.sphchina.com

Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.

Shanghai Pharmaceuticals Holding Co (SHSE:601607) Headlines

No Headlines